| Title: |
Sexual Practices and HIV Prevention Strategies Used by Female Sex Workers in Lagos, Nigeria: An Assessment of the Willingness to Use a Microbicide. |
| Authors: |
Ekama, Sabdat Ozichu; Sheth, Anandi N; Ilomuanya, Margaret O; Okwuzu, Jane Ogoamaka; Musa, Adesola Zaidat; Idigbe, Ifeoma; Ezeobi, Paschal Mbanefo; Oladele, David Ayoola; Ezechi, Oliver Chukwujekwu; Salako, Babatunde Lawal |
| Source: |
HIV/AIDS - Research & Palliative Care; Feb2025, Vol. 17, p19-28, 10p |
| Subject Terms: |
Human sexuality; Unsafe sex; Sexual intercourse; Anal sex; HIV prevention |
| Abstract: |
Background: Female sex workers have a 13-fold higher risk of acquiring HIV than women who do not engage in sex work. The willingness and acceptability of a product is crucial for the development of microbicides. This research aimed to evaluate the sexual practices, existing HIV prevention methods, and willingness to use a microbicide for HIV prevention among female sex workers in Nigeria. We also explored factors that might influence their willingness to use a new microbicide product. Methods: A cross-sectional study was conducted among female sex workers recruited from brothels within Lagos-Nigeria, in which participants were selected via purposive sampling over a period of five-months. An interviewer-administered, semi-structured questionnaire was used to obtain information. Descriptive statistics were used to present the results, and a multiple logistic regression model was used to determine the factors associated with willingness to use a microbicide. Results: A total of 461 female participants with a mean-age of 29.63 ± 8.8 years were included in the analysis of which 34.3% had > 4 sexual partners, 91.8% used condoms, 53.6% engaged in anal sex, 69.6% had experienced condom rupture, and 31% would "accept unprotected sex" if the male partner refuses to use a condom. Approximately 43% had received PEP, of which only 15% completed the one-month PEP-regimen. On the other hand, 64.6% had taken PrEP medications, of which 28% admitted skipping doses. Although 41% were concerned about male partner acceptance, a total of 95% will be willing to use a microbicide. The number of sexual partners ([aOR] 1.555; 95% Cl 1.035– 2.335), use of condoms ([aOR] 4.701; 95% Cl 1.418– 15.584), and condom rupture experience ([aOR] 2.550; 95% Cl 1.817− 7.959) were associated with greater odds of willingness to use an HIV microbicide. Conclusion: There is a high level of willingness to use a future microbicide among the female commercial sex workers in this study. In addition, majority of the participants will prefer a microbicide product that is female controlled, affordable, and provided as an over-the-counter medication. This cohort of women engage in high-risk sexual practices and play a significant role in HIV prevention efforts. Therefore, their product preferences and concerns should be considered in microbicide development to enhance the acceptability, adherence, and efficacy of future microbicides. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of HIV/AIDS - Research & Palliative Care is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |